Revolution Medicines Eulerpool News

Revolution Medicines Stock News

Revolution Medicines is being monitored by journalists and investors worldwide. We gather the latest Revolution Medicines news here.

• November 21 ·

  SeekingAlpha
  Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy
• November 18 ·

  SeekingAlpha
  Revolution Medicines, Inc. (RVMD) Presents at Jefferies London Healthcare Conference 2025 Transcript
• November 11 ·

  SeekingAlpha
  Revolution Medicines, Inc. (RVMD) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
• November 7 ·

  Yahoo
  Revolution Medicines (RVMD): Assessing Valuation After Recent 28% Monthly Share Price Surge
• November 6 ·

  Yahoo
  Revolution Medicines Inc (RVMD) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
• November 6 ·

  Yahoo
  Revolution Medicines (RVMD) Earnings Transcript
• November 5 ·

  Yahoo
  Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
• November 3 ·

  Yahoo
  Boeing upgraded, Charter downgraded: Wall Street's top analyst calls
• October 29 ·

  Yahoo
  Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025
• October 27 ·

  Yahoo
  Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer